Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

Affiliations

• ¹ Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
• ² Dana-Farber Cancer Institute, Boston, MA, USA.
• ³ Department of Clinical Therapeutics, University of Athens, Athens, Greece.
• ⁴ University Hospital, Nantes, France.
• ⁵ MD Anderson Cancer Center, Houston, TX, USA.
• ⁶ Merck & Co. Inc., Whitehouse Station, NJ, USA.
• ⁷ Pharmacyclics Inc., Sunnyvale, CA, USA.
• ⁸ Department of Medicine, Harvard Medical School and Kraft Family Blood Center, Dana-Farber Cancer Institute, Boston, MA, USA.